Literature DB >> 21719646

AIDS: let science inform policy.

Anthony S Fauci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21719646     DOI： 10.1126/science.1209751

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.

Authors:  Lian-Qi Sun; Bingjie Qin; Li Huang; Keduo Qian; Chin-Ho Chen; Kuo-Hsiung Lee; Lan Xie
Journal:  Bioorg Med Chem Lett       Date:  2012-02-24       Impact factor: 2.823

2.  'Slipping through the cracks': policy implications of delays in HIV treatment seeking.

Authors:  Janet W McGrath; David Kaawa-Mafigiri; Sarah Bridges; Nelson Kakande
Journal:  Glob Public Health       Date:  2012-07-19

3.  Beyond surveillance: a role for respondent-driven sampling in implementation science.

Authors:  Sunil S Solomon; Gregory M Lucas; David D Celentano; Frangiscos Sifakis; Shruti H Mehta
Journal:  Am J Epidemiol       Date:  2013-06-25       Impact factor: 4.897

4.  Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission.

Authors:  Thao Do; Gavin Murphy; Lesley A Earl; Gregory Q Del Prete; Giovanna Grandinetti; Guan-Han Li; Jacob D Estes; Prashant Rao; Charles M Trubey; James Thomas; Jeffrey Spector; Donald Bliss; Avindra Nath; Jeffrey D Lifson; Sriram Subramaniam
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

5.  Central implementation strategies outperform local ones in improving HIV testing in Veterans Healthcare Administration facilities.

Authors:  Matthew Bidwell Goetz; Tuyen Hoang; Herschel Knapp; Jane Burgess; Michael D Fletcher; Allen L Gifford; Steven M Asch
Journal:  J Gen Intern Med       Date:  2013-04-19       Impact factor: 5.128

6.  Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.

Authors:  Lian-Qi Sun; Lei Zhu; Keduo Qian; Bingjie Qin; Li Huang; Chin Ho Chen; Kuo-Hsiung Lee; Lan Xie
Journal:  J Med Chem       Date:  2012-08-10       Impact factor: 7.446

7.  The evolving landscape of the economics of HIV treatment and prevention.

Authors:  Bohdan Nosyk; Julio S G Montaner
Journal:  PLoS Med       Date:  2012-02-14       Impact factor: 11.069

8.  Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India.

Authors:  Sunil S Solomon; Gregory M Lucas; David D Celentano; Allison M McFall; Elizabeth Ogburn; Lawrence H Moulton; Aylur K Srikrishnan; M Suresh Kumar; Santhanam Anand; Suniti Solomon; Shruti H Mehta
Journal:  BMC Health Serv Res       Date:  2016-11-14       Impact factor: 2.655

Review 9.  Quasi-experiments to establish causal effects of HIV care and treatment and to improve the cascade of care.

Authors:  Jacob Bor; Pascal Geldsetzer; Atheendar Venkataramani; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.061
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.